Analysis of HbA1c using microfluidic card (Capitainer qDBS card) as a pre-step before determination of the HbA1c value with an immunological method

Scandinavian Journal of Clinical and Laboratory Investigation, Год журнала: 2024, Номер 84(1), С. 11 - 15

Опубликована: Янв. 19, 2024

The objective of the study was to evaluate Capitainer's quantitative dried blood spots (qDBS) card for Hemoglobin A1c (HbA1c) testing. qDBS cards can be used at-home sampling HbA1c determination in a Swedish laboratory setting. A total 153 routine requested samples were this evaluation microfluidic (qDBS). extracted from disc and determined at cobas 6000 instruments with immunological technology. results compared traditional venous reproducibility using elution procedure 4.0% measured as coefficient variation concentration 51 mmol/mol. Analytical performance specifications < 52 mmol/mol DBS (c501) assigned values Capillarys 3 (y) = 1.03 x 3(x) − 0.87; R2 0.97. There is good agreement between by testing cards. This shows that technology could out-of doctor's office

Язык: Английский

---

Blood self-sampling: friend or foe?

Clinical Chemistry and Laboratory Medicine (CCLM), Год журнала: 2024, Номер 63(1), С. 1 - 2

Опубликована: Окт. 9, 2024

---

Acceptability and preliminary efficacy of a novel web-based physical activity for the heart (PATH) intervention designed to promote physical activity in adults with obesity: Protocol for a pilot randomized controlled trial (Preprint)

Опубликована: Окт. 25, 2024

Even in the absence of weight-loss, any level physical activity (PA) can reduce risk CVD among individuals with obesity. However, these face multifaceted barriers that their motivation and engagement PA. They prefer programs are convenient, fun to engage in, feature people who they relate to. Yet, there is a paucity PA interventions designed incorporate preferences. We web-based for The Heart (PATH) intervention address this gap. To describe protocol study aims examine acceptability preliminary efficacy PATH 88 insufficiently active adults obesity aged at least 18 years old. A 6-month pilot randomized controlled trial (RCT), using parallel design 1:1 allocation or control group. group given access platform, but resources each participant tailored according baseline fitness level. Control receive self-help handout. Both self-monitor Fitbit have twice/month meetings either health coach (intervention) coordinator (control). outcomes 6-months include acceptability, changes cardiometabolic factors from 6-months. N/A offers promising, evidence-based approach overcoming hindered previous It support new existing program foster long-term maintenance health-enhancing NCT05803304

Язык: Английский

---

Acceptability and preliminary efficacy of a novel web-based physical activity for the heart (PATH) intervention designed to promote physical activity in adults with obesity: Protocol for a pilot randomized controlled trial (Preprint)

JMIR Research Protocols, Год журнала: 2024, Номер unknown

Опубликована: Окт. 25, 2024

Even in the absence of weight loss, any level physical activity (PA) can reduce risk cardiovascular disease among individuals with obesity. However, these face multifaceted barriers that their motivation and engagement PA. They prefer programs are convenient, fun to engage in, feature people who they relate to. Yet, there is a paucity PA interventions designed incorporate preferences. We web-based for The Heart (PATH) intervention address this gap. This study aimed describe protocol aims examine acceptability preliminary efficacy PATH insufficiently active adults obesity aged at least 18 years. 6-month pilot randomized controlled trial (RCT), using parallel design 1:1 allocation or control group. group given access platform, but resources each participant tailored according baseline fitness level. Control receives self-help handout. Both groups self-monitor Fitbit (Google) have Zoom (Zoom Video Communications) meetings twice month either health coach (intervention) coordinator (control). outcomes 6-months include acceptability, changes PA, cardiometabolic from 6-months. screened 763 eligibility 89 participants were enrolled (45/504, 50.6%) arms (44/504, 49.4%). average age was 48.7 (SD 12.17) years, most female (81/504, 90.1%), Black 50.6%), non-Hispanic (83/504, 93.3%). No systematic differences characteristics observed between arms. currently underway, completion follow-up data collection expected February 2025, results be published soon after. offers promising, evidence-based approach overcoming hindered previous It support new existing foster long-term maintenance health-enhancing ClinicalTrials.gov NCT05803304; https://clinicaltrials.gov/study/NCT05803304. DERR1-10.2196/67972.

Язык: Английский

---

Biological management of diabetes mellitus, the laboratory medicine specialist and the patient

Clinical Chemistry and Laboratory Medicine (CCLM), Год журнала: 2023, Номер 62(1), С. 1 - 2

Опубликована: Сен. 8, 2023

Язык: Английский

---